Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.24 CHF | -0.37% |
|
-4.63% | -9.96% |
05-29 | Cooper Companies raises 2025 profit forecast on contact lens demand | RE |
05-29 | US FDA approves Alcon's new dry-eye drug (May 28) | RE |
Capitalization | 41.9B 36.54B 34.32B 31.21B 57.56B 3,639B 64.92B 405B 156B 1,658B 157B 154B 6,107B | P/E ratio 2025 * |
40.4x | P/E ratio 2026 * | 28.9x |
---|---|---|---|---|---|
Enterprise value | 43.86B 38.25B 35.93B 32.67B 60.25B 3,810B 67.96B 424B 164B 1,736B 165B 161B 6,393B | EV / Sales 2025 * |
4.2x | EV / Sales 2026 * | 3.78x |
Free-Float |
98.82% | Yield 2025 * |
0.37% | Yield 2026 * | 0.45% |
More valuation ratios
* Estimated data
More news
Last Transcript: Alcon Inc.
More recommendations
More press releases
More news
1 day | -0.37% | ||
1 week | -4.63% | ||
Current month | -2.07% | ||
1 month | -6.53% | ||
3 months | -13.17% | ||
6 months | -8.61% | ||
Current year | -9.96% |
1 week | 68.7 | ![]() | 70.86 |
1 month | 68.7 | ![]() | 73.98 |
Current year | 67.34 | ![]() | 87 |
1 year | 67.34 | ![]() | 87 |
3 years | 55.22 | ![]() | 87 |
5 years | 49.89 | ![]() | 87 |
10 years | 38.62 | ![]() | 87 |
Manager | Title | Age | Since |
---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 59 | 2018-06-30 |
Director of Finance/CFO | 57 | 2019-04-07 | |
Patrick Collier
CTO | Chief Tech/Sci/R&D Officer | - | 2024-12-31 |
Director | Title | Age | Since |
---|---|---|---|
David Endicott
BRD | Director/Board Member | 59 | - |
F. Ball
CHM | Chairman | 69 | 2018-06-30 |
Lynn Bleil
BRD | Director/Board Member | 61 | 2019-01-31 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
3.96% | 121 M€ | -.--% | - | |
1.24% | 21 M€ | +0.39% | - | |
0.41% | 898 M€ | -1.08% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.37% | -4.63% | -11.86% | +8.46% | 42.17B | ||
-0.46% | -2.59% | +17.74% | +72.57% | 128B | ||
+1.56% | -1.48% | -23.82% | -8.40% | 13.93B | ||
-2.15% | -4.90% | +38.97% | +57.41% | 2.59B | ||
+0.91% | -3.73% | +188.74% | +664.27% | 2.27B | ||
-1.14% | -4.80% | -12.83% | -73.44% | 1.85B | ||
-1.71% | +4.08% | +105.15% | +43.16% | 1.33B | ||
-0.83% | -6.57% | -37.55% | -29.18% | 795M | ||
-2.81% | -7.32% | -23.69% | -21.39% | 561M | ||
+5.85% | +5.86% | -18.53% | -62.45% | 535M | ||
Average | -0.11% | -1.80% | +22.23% | +65.10% | 19.43B | |
Weighted average by Cap. | -0.31% | -3.08% | +10.47% | +56.89% |
2025 * | 2026 * | |
---|---|---|
Net sales | 10.44B 9.1B 8.55B 7.77B 14.34B 906B 16.17B 101B 38.94B 413B 39.16B 38.33B 1,521B | 11.28B 9.84B 9.24B 8.4B 15.49B 980B 17.48B 109B 42.09B 446B 42.33B 41.42B 1,644B |
Net income | 1.05B 919M 864M 785M 1.45B 91.57B 1.63B 10.19B 3.93B 41.72B 3.96B 3.87B 154B | 1.45B 1.27B 1.19B 1.08B 1.99B 126B 2.25B 14.02B 5.41B 57.41B 5.44B 5.33B 211B |
Net Debt | 1.96B 1.71B 1.61B 1.46B 2.69B 170B 3.04B 18.96B 7.32B 77.63B 7.36B 7.2B 286B | 715M 623M 586M 533M 982M 62.1B 1.11B 6.91B 2.67B 28.29B 2.68B 2.63B 104B |
More financial data
* Estimated data
Employees
25,000
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-06-19 | 69.24 CHF | -0.37% | 690,936 |
25-06-18 | 69.50 CHF | -0.80% | 792,902 |
25-06-17 | 70.06 CHF | +0.37% | 744,902 |
25-06-16 | 69.80 CHF | -1.55% | 768,274 |
25-06-13 | 70.90 CHF | -2.34% | 760,781 |
Delayed Quote Swiss Exchange, June 19, 2025 at 11:31 am
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
26
Last Close Price
84.53USD
Average target price
107.55USD
Spread / Average Target
+27.24%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALC Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition